Broadcom Shares Tumble Despite AI Revenue, Should You Buy?
Broadcom has faced a stock pullback even as AI-driven revenue climbs. This article digs into the reasons behind the d...
When To Adjust Investments For Retirement
Knowing when to adjust investments for retirement is crucial. Stay ahead by learning the best times and strategies for optimal financial health.
16,299 articles
Silver Miners ETF Slumps After 434% Rally, 12% Drop Today
The Silver Miners ETF (SLVR) reversed a rapid rise with a sharp one-day decline, underscoring the risk built into lev...
Amplitude's Co-Founder Chief Technology: Investor Insights
A high-profile insider sale at Amplitude raises questions for investors. This guide breaks down what amplitude's co-f...
Mortgage Credit Availability Edges Higher in May as Jumbo
May data show mortgage credit availability edges higher, led by a small loosening in jumbo loan programs despite high...
Why J.M. Smucker Stock Jumped Today: Key Drivers and Implications
When the market wakes up to a notable move in Smucker shares, it often signals more than a one-off beat. This article...
The Curse Trump Watching Sports: A Market Oddity Today
A betting meme links celebrity attendance to home-team losses, prompting bettors to rethink risk in personal finance ...
Io.Net Unveils Incentive Dynamic Engine for Tokenomics
Io.Net introduces an incentive framework designed to align rewards with real network contribution, aiming to stabiliz...
UnitedHealth Group Just 52-Week High: Is It Too Late to Buy?
UnitedHealth Group just 52-week highs spark questions about sustainability. This guide breaks down what's driving the...
Roche Nestlé Fear Talent as Swiss Population Cap Vote Looms
As Switzerland heads to the polls on a population cap, the country’s biotech and food giants warn that limiting immig...
NVIDIA Jensen Huang Says This Could Fuel a $1 Trillion Rise
NVIDIA's leadership and AI-driven demand are reshaping the stock market landscape. This article dives into what Jense...
Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Anthropic Faces Lawsuit Over Misleading Claude Pricing
A new class-action alleges that Anthropic overstated Claude Max usage limits and the promised savings. The case could...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status